Close
  Indian J Med Microbiol
 

Figure 2: Kaplan–Meier plot comparing overall survival and progression-free survival (PFS) for patients receiving different treatment regimens (a) PFS was significantly different between the chemotherapy + highly active antiretroviral therapy (HAART) group and the nontreatment group (P = 0.04). (b) PFS was significantly different between the HAART before chemotherapy group and the non-treatment group (P = 0.016)

Figure 2: Kaplan–Meier plot comparing overall survival and progression-free survival (PFS) for patients receiving different treatment regimens (a) PFS was significantly different between the chemotherapy + highly active antiretroviral therapy (HAART) group and the nontreatment group (<i>P</i> = 0.04). (b) PFS was significantly different between the HAART before chemotherapy group and the non-treatment group (<i>P</i> = 0.016)